Skip to main content
. 2017 Aug 18;36(12):2655–2665. doi: 10.1007/s10067-017-3788-1

Table 2.

Clinical response or mean change from baseline at month 6 by BMI

SC abatacept IV abatacept Pooled SC/IV abatacept
Underweight/
normal BMI
Overweight BMI Obese BMI Underweight/
normal BMI
Overweight BMI Obese BMI Underweight/
normal BMI
Overweight BMI Obese BMI
TJC28 −11.8 (0.4)
(−12.6,
−11.0)
−11.2 (0.5)
(−12.1,
−10.3)
−11.9 (0.5)
(−12.9,
−10.9)
−10.9 (0.4)
(−11.7,
−10.1)
−11.6 (0.4)
(−12.5,
−10.8)
−11.5 (0.5)
(−12.4,
−10.6)
−11.4 (0.3)
(−11.9,
−10.8)
−11.4 (0.3)
(−12.0,
−10.8)
−11.7 (0.4)
(−12.4,
−11.0)
SJC28 −10.3 (0.4)
(−11.1, −9.6)
−8.2 (0.4)
(−8.9, −7.4)
−10.3 (0.4)
(−11.2, −9.5)
−9.7 (0.3)
(−10.3, −9.0)
−8.8 (0.4)
(−9.6, −8.1)
−9.8 (0.4)
(−10.5, −9.0)
−10.0 (0.3)
(−10.5, −9.5)
−8.5 (0.3)
(−9.0, −8.0)
−10.0 (0.3)
(−10.6, −9.5)
hsCRP, mg/dL −2.0 (0.2)
(−2.4, −1.7)
−1.5 (0.2)
(−1.8, −1.2)
−0.7 (0.2)
(−1.0, −0.4)
−1.9 (0.2)
(−2.3, −1.5)
−1.4 (0.2)
(−1.8, −1.1)
−1.1 (0.2)
(−1.5, −0.7)
−2.0 (0.1)
(−2.2, −1.7)
−1.5 (0.1)
(−1.7, −1.2)
−0.9 (0.1)
(−1.1, −0.6)
DAS28 (CRP) remission, % (95% CI) 27.3
(21.7, 32.9)
20.0
(14.9, 25.1)
25.4
(19.4, 31.4)
25.0
(19.5, 30.5)
30.0
(24.0, 35.9)
18.5
(13.0, 23.9)
26.2
(22.2, 30.1)
24.9
(20.9, 28.8)
22.0
(17.9, 26.0)
SDAI remission, % (95% CI) 9.1
(5.5, 12.7)
12.0
(7.8, 16.1)
11.9
(7.5, 16.4)
10.6
(6.7, 14.6)
11.5
(7.3, 15.7)
9.8
(5.6, 14.0)
9.9
(7.2, 12.5)
11.7
(8.8, 14.7)
10.9
(7.8, 14.0)
CDAI remission, % (95% CI) 9.0
(5.4, 12.6)
13.1
(8.8, 17.4)
14.3
(9.5, 19.1)
11.8
(7.7, 15.9)
13.7
(9.2, 18.1)
11.8
(7.3, 16.3)
10.4
(7.6, 13.1)
13.4
(10.3, 16.5)
13.1
(9.8, 16.4)
PtGA, 100 mm VAS −36.7 (1.6)
(−39.8,
−33.6)
−35.8 (1.7)
(−39.1,
−32.4)
−33.8 (2.0)
(−37.7,
−29.8)
−34.7 (1.7)
(−37.9,
−31.4)
−33.8 (1.7)
(−37.1, −30.6)
−30.8 (2.0)
(−34.8, −26.9)
−35.7 (1.2)
(−37.9, −33.4)
−34.8 (1.2)
(−37.1, −32.5)
−32.3 (1.4)
(−35.1, −29.5)

Data are mean (standard deviation) (95% confidence interval) change from baseline unless indicated otherwise

CDAI Clinical Disease Activity Index, CRP C-reactive protein, DAS28 Disease Activity Score 28, hsCRP high-sensitivity CRP, IV intravenous, PtGA patient global assessment, SC subcutaneous, SDAI Simplified Disease Activity Index, SJC28 swollen joint count-28 joints, TJC28 tender joint count-28 joints, VAS visual analogue scale